Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Shanghai Haohai Biological Technology Co Ltd
SSE:688366
Price:
59.08
CNY
-0.89%
Market Closed
Market Cap:
13.8B
CNY
Income Statement
Earnings Waterfall
Shanghai Haohai Biological Technology Co Ltd
Shanghai Haohai Biological Technology Co Ltd
|
Revenue
|
2.7B
CNY
|
|
Cost of Revenue
|
-852.3m
CNY
|
|
Gross Profit
|
1.9B
CNY
|
|
Operating Expenses
|
-1.4B
CNY
|
|
Operating Income
|
457.8m
CNY
|
|
Other Expenses
|
-27.6m
CNY
|
|
Net Income
|
430.2m
CNY
|
Income Statement
Shanghai Haohai Biological Technology Co Ltd
Shanghai Haohai Biological Technology Co Ltd
Currency: CNY
Millions
TTM
| Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Revenue |
1 615
N/A
|
1 604
-1%
|
1 446
-10%
|
1 315
-9%
|
1 352
+3%
|
1 332
-1%
|
1 561
+17%
|
1 688
+8%
|
1 715
+2%
|
1 767
+3%
|
1 858
+5%
|
1 884
+1%
|
2 075
+10%
|
2 130
+3%
|
2 268
+6%
|
2 475
+9%
|
2 530
+2%
|
2 654
+5%
|
2 689
+1%
|
2 746
+2%
|
2 747
+0%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
(383)
|
(365)
|
(333)
|
(302)
|
(322)
|
(338)
|
(404)
|
(449)
|
(467)
|
(492)
|
(566)
|
(582)
|
(652)
|
(669)
|
(692)
|
(762)
|
(762)
|
(790)
|
(823)
|
(833)
|
(852)
|
|
| Gross Profit |
1 232
N/A
|
1 240
+1%
|
1 113
-10%
|
1 013
-9%
|
1 030
+2%
|
995
-3%
|
1 157
+16%
|
1 238
+7%
|
1 248
+1%
|
1 275
+2%
|
1 292
+1%
|
1 302
+1%
|
1 422
+9%
|
1 461
+3%
|
1 576
+8%
|
1 713
+9%
|
1 767
+3%
|
1 864
+6%
|
1 866
+0%
|
1 912
+2%
|
1 895
-1%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(829)
|
(889)
|
(902)
|
(925)
|
(947)
|
(872)
|
(888)
|
(852)
|
(881)
|
(1 041)
|
(1 089)
|
(1 217)
|
(1 285)
|
(1 255)
|
(1 365)
|
(1 386)
|
(1 416)
|
(1 426)
|
(1 418)
|
(1 448)
|
(1 437)
|
|
| Selling, General & Administrative |
(757)
|
(765)
|
(828)
|
(855)
|
(851)
|
(722)
|
(782)
|
(731)
|
(754)
|
(816)
|
(943)
|
(1 064)
|
(1 126)
|
(988)
|
(1 169)
|
(1 184)
|
(1 207)
|
(1 131)
|
(1 216)
|
(1 219)
|
(1 208)
|
|
| Research & Development |
(128)
|
(110)
|
(120)
|
(121)
|
(121)
|
(115)
|
(135)
|
(143)
|
(156)
|
(153)
|
(177)
|
(171)
|
(175)
|
(171)
|
(190)
|
(207)
|
(215)
|
(209)
|
(231)
|
(244)
|
(254)
|
|
| Depreciation & Amortization |
0
|
(60)
|
0
|
0
|
0
|
(68)
|
0
|
0
|
0
|
(103)
|
0
|
0
|
0
|
(134)
|
0
|
0
|
0
|
(125)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
56
|
46
|
45
|
51
|
24
|
33
|
29
|
23
|
30
|
31
|
31
|
18
|
17
|
38
|
(6)
|
5
|
5
|
39
|
29
|
16
|
25
|
|
| Operating Income |
403
N/A
|
350
-13%
|
210
-40%
|
88
-58%
|
83
-6%
|
122
+48%
|
270
+120%
|
387
+43%
|
367
-5%
|
234
-36%
|
203
-13%
|
85
-58%
|
138
+62%
|
206
+50%
|
211
+2%
|
327
+55%
|
351
+7%
|
439
+25%
|
447
+2%
|
464
+4%
|
458
-1%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
85
|
95
|
110
|
131
|
147
|
137
|
134
|
136
|
133
|
150
|
135
|
122
|
100
|
74
|
65
|
58
|
62
|
68
|
62
|
57
|
48
|
|
| Non-Reccuring Items |
(1)
|
(10)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(47)
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(1)
|
2
|
2
|
2
|
2
|
1
|
(0)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
485
N/A
|
434
-10%
|
319
-27%
|
218
-32%
|
228
+5%
|
257
+13%
|
402
+56%
|
520
+29%
|
498
-4%
|
383
-23%
|
338
-12%
|
206
-39%
|
237
+15%
|
236
0%
|
278
+18%
|
388
+40%
|
416
+7%
|
508
+22%
|
510
+0%
|
521
+2%
|
505
-3%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
(62)
|
(58)
|
(45)
|
(26)
|
(21)
|
(31)
|
(48)
|
(69)
|
(60)
|
(35)
|
(26)
|
(21)
|
(37)
|
(45)
|
(66)
|
(63)
|
(65)
|
(96)
|
(91)
|
(100)
|
(104)
|
|
| Income from Continuing Operations |
424
|
376
|
274
|
192
|
207
|
226
|
354
|
451
|
438
|
347
|
311
|
184
|
199
|
190
|
212
|
325
|
351
|
412
|
420
|
421
|
401
|
|
| Income to Minority Interest |
(37)
|
(6)
|
6
|
24
|
26
|
4
|
(2)
|
(18)
|
(10)
|
5
|
5
|
8
|
4
|
(10)
|
(11)
|
(10)
|
(6)
|
4
|
13
|
25
|
29
|
|
| Net Income (Common) |
387
N/A
|
371
-4%
|
279
-25%
|
216
-23%
|
232
+8%
|
230
-1%
|
352
+53%
|
434
+23%
|
428
-1%
|
352
-18%
|
316
-10%
|
192
-39%
|
203
+6%
|
180
-11%
|
201
+11%
|
315
+57%
|
346
+10%
|
416
+20%
|
432
+4%
|
446
+3%
|
430
-4%
|
|
| EPS (Diluted) |
2.42
N/A
|
2.27
-6%
|
1.57
-31%
|
1.21
-23%
|
1.32
+9%
|
1.3
-2%
|
2
+54%
|
2.47
+24%
|
2.44
-1%
|
1.43
-41%
|
1.8
+26%
|
1.1
-39%
|
1.16
+5%
|
0.74
-36%
|
1.16
+57%
|
1.85
+59%
|
1.41
-24%
|
1.74
+23%
|
1.83
+5%
|
1.93
+5%
|
1.83
-5%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
